Adam Hanina

Adam Hanina has a diverse work experience in various leadership roles. Adam is currently the CEO of Dandelion Science Corp, a neurocoding company focused on advancing our understanding of the brain. Prior to that, they were the founder and CEO of AiCure, a technology company. Adam also worked in private equity at WMAM and served as the Executive Director of the European eHealth Forum. In addition, Adam Hanina held a role in European business development at Cerner Corporation and worked as the Managing Director at Biodeo, where they were responsible for corporate strategy and international business development.

Adam Hanina began their education at St Paul's School in London, where they studied from 1989 to 1994. Adam then pursued a Bachelor of Arts degree with Honors in Physics at Brown University, attending from 1994 to 1998. After that, they completed a Master of Philosophy degree in Management at the University of Cambridge, from 1998 to 1999. Lastly, Adam attended The Wharton School from 2005 to 2007, where they obtained a Master of Business Administration degree.